A slow immune response to SARS-CoV-2 infection, delayed viral clearance, and viral rebound can all increase a person’s risk ...

Increasing HPV vaccination rates could help decrease the number of cancer cases “attributable to HIV,” according to data from ...

Previous research has suggested an increased risk for neuropsychiatric symptoms in people living with HIV who are being ...

For household contacts of individuals with COVID-19, taking ensitrelvir within 72 hours of symptoms is effective at ...

A single shot of a new formulation of the antiretroviral drug lenacapavir could potentially provide protection against HIV ...

Injections of semaglutide were associated with significant improvement in cognitive function in people living with HIV (PWH), ...

Dar/Nairobi. A ground-breaking HIV clinical trial in Africa has demonstrated that some women can control the virus without ...

The clinical trial, dubbed FRESH and conducted in Durban, South Africa, revealed that four out of 20 women with acute HIV ...

The study aimed to reduce traces of HIV in the body and help the immune system fight the virus without chronic medication.

A single shot of a new formulation of the antiretroviral drug lenacapavir could potentially provide protection against HIV infection for as long as a year. Spotlight reports on this and some of the ...

A total of 9% of placebo recipients contracted COVID-19 from a household member, compared with 3% of ensitrelvir recipients, ...

References Gianella Weibel S et al. Letermovir for CMV suppression improves immunologic and functional aging outcomes in treated HIV. Conference on Retroviruses and Opportunistic Infections, San ...